Home/Filings/4/0001104659-24-077875
4//SEC Filing

Tananbaum James B. 4

Accession 0001104659-24-077875

CIK 0001847367other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 9:30 PM ET

Size

72.5 KB

Accession

0001104659-24-077875

Insider Transaction Report

Form 4
Period: 2024-07-01
Tananbaum James B.
Director10% Owner
Transactions
  • Conversion

    Common Stock

    2024-07-01+311,1721,278,739 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+311,172311,172 total(indirect: See Footnote)
  • Conversion

    Series B-1 Redeemable Convertible Preferred Stock

    2024-07-01560,0760 total(indirect: See Footnote)
    Common Stock (560,076 underlying)
  • Conversion

    Series C Redeemable Convertible Preferred Stock

    2024-07-01681,5980 total(indirect: See Footnote)
    Common Stock (681,598 underlying)
  • Conversion

    Series B-1 Redeemable Convertible Preferred Stock

    2024-07-01967,5670 total(indirect: See Footnote)
    Common Stock (967,567 underlying)
  • Conversion

    Series B-2 Redeemable Convertible Preferred Stock

    2024-07-01311,1720 total(indirect: See Footnote)
    Common Stock (311,172 underlying)
  • Conversion

    Series B-2 Redeemable Convertible Preferred Stock

    2024-07-01311,1720 total(indirect: See Footnote)
    Common Stock (311,172 underlying)
  • Conversion

    Series B-2 Redeemable Convertible Preferred Stock

    2024-07-01311,1720 total(indirect: See Footnote)
    Common Stock (311,172 underlying)
  • Conversion

    Series C Redeemable Convertible Preferred Stock

    2024-07-011,703,9980 total(indirect: See Footnote)
    Common Stock (1,703,998 underlying)
  • Conversion

    Common Stock

    2024-07-01+1,944,5771,944,577 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+1,122,9943,067,571 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+560,0763,627,647 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+622,3444,249,991 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+1,022,3985,272,389 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2024-07-01$16.00/sh+312,500$5,000,0005,584,889 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+194,459194,459 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+481,283481,283 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+560,0761,041,359 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+311,1721,352,531 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+681,5982,034,129 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+967,567967,567 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+681,5981,960,337 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2024-07-01+1,703,9982,015,170 total(indirect: See Footnote)
  • Purchase

    Common Stock

    2024-07-01$16.00/sh+2,187,500$35,000,0004,202,670 total(indirect: See Footnote)
  • Conversion

    Series Seed Redeemable Convertible Preferred Stock

    2024-07-011,944,5770 total(indirect: See Footnote)
    Common Stock (1,944,577 underlying)
  • Conversion

    Series Seed Redeemable Convertible Preferred Stock

    2024-07-01194,4590 total(indirect: See Footnote)
    Common Stock (194,459 underlying)
  • Conversion

    Series A Redeemable Convertible Preferred Stock

    2024-07-011,122,9940 total(indirect: See Footnote)
    Common Stock (1,122,994 underlying)
  • Conversion

    Series A Redeemable Convertible Preferred Stock

    2024-07-01481,2830 total(indirect: See Footnote)
    Common Stock (481,283 underlying)
  • Conversion

    Series B-1 Redeemable Convertible Preferred Stock

    2024-07-01560,0760 total(indirect: See Footnote)
    Common Stock (560,076 underlying)
  • Conversion

    Series B-2 Redeemable Convertible Preferred Stock

    2024-07-01622,3440 total(indirect: See Footnote)
    Common Stock (622,344 underlying)
  • Conversion

    Series C Redeemable Convertible Preferred Stock

    2024-07-01681,5980 total(indirect: See Footnote)
    Common Stock (681,598 underlying)
  • Conversion

    Series C Redeemable Convertible Preferred Stock

    2024-07-011,022,3980 total(indirect: See Footnote)
    Common Stock (1,022,398 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,176,470
Footnotes (7)
  • [F1]Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series Seed Redeemable Convertible Preferred Stock, Series A Redeemable Convertible Preferred Stock, Series B-1 Redeemable Convertible Preferred Stock, Series B-2 Redeemable Convertible Preferred Stock and Series C Redeemable Convertible Preferred Stock automatically converted into one share of Common Stock and has no expiration date.
  • [F2]The shares are held of record by Foresite Capital Fund V, L.P. ("Fund V"). Foresite Capital Management V, LLC ("FCM V") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities.
  • [F3]The shares are held of record by Labs Co-Invest V, LLC ("Labs Co-Invest"). FCM V is the managing member of Labs Co-Invest and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Co-Invest, except to the extent of such person's pecuniary interest in such securities.
  • [F4]The shares are held of record by Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"). Foresite Capital Opportunity Management V, LLC ("FCOM V") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities.
  • [F5]The shares are held of record by Foresite Labs Fund I, L.P. ("Labs Fund I"). Foresite Labs Management I, LLC ("FLM I") is the general partner of Labs Fund I and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FLM I, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Fund I, except to the extent of such person's pecuniary interest in such securities.
  • [F6]The shares are held of record by Foresite Capital Fund VI, L.P. ("Fund VI"). Foresite Capital Management VI, LLC ("FCM VI") is the general partner of Fund VI and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCM VI, may be deemed to have sole voting and dispositive power over such shares. Tananbaum disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Fund VI, except to the extent of such person's pecuniary interest in such securities.
  • [F7]The shares are held of record by Foresite Labs Affiliates 2021, LLC ("Labs Affiliates"). Foresite Labs, LLC ("Labs") is the managing member of Labs Affiliates and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, a manager of Labs, may be deemed to share voting and dispositive power over such shares. Tananbaum disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and disclaims beneficial ownership of the shares held by Labs Affiliates, except to the extent of such person's pecuniary interest in such securities.

Issuer

ALUMIS INC.

CIK 0001847367

Entity typeother

Related Parties

1
  • filerCIK 0001581754

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 9:30 PM ET
Size
72.5 KB